Great! You have sucessfully subscribed for newsletters for investments
Subscribed email:
Nippon India Pharma Fund Direct-Growth
| NAV as of Oct 20, 2025 | Returns since inception | ET Money Rank | AUM (Fund size) |
|---|---|---|---|
| ₹577.1389+0.63% 1 day change | 17.89% | App exclusive   | ₹8,114 Cr |
Historical NAV & returns
NAV: ₹577.1389 as on Oct 20, 2025
Loading...
Nippon India Pharma Fund overview
| Expense ratio | 0.91% as on Sep 30, 2025 |
| Exit load | 1.0% Exit load of 1% if redeemed within 1 month.! |
| AUM (Fund size) | ₹8,114 Cr |
| Lock-in Period | Nil |
| Age | 12 yrs 9 m since Jan 01, 2013 |
| Benchmark | BSE Healthcare TRI |
| Min. investment | SIP: ₹500 & Lumpsum: ₹5000 |
| Risk | Very High |
| Short term capital gains (STCG) | Returns taxed at 20% if you redeem before 1 year |
| Long term capital gains (LTCG) | After 1 year, returns above ₹1.25 lakh in a financial year are taxed at 12.5% |
Nippon India Pharma Fund Returns calculator
Investment type
- Total investment ₹ 12 lakh
- Profit ₹12 lakhs
- Total corpus ₹1 lakh
- Absolute return 52.69%
Trailing returns as on Oct 25, 2025
| Period | This fund | Category average |
|---|---|---|
| 1 Month | 1.62% | 2.25% |
| 3 Months | -2.37% | -0.39% |
| 6 Months | 5.09% | 8.17% |
| 1 Year | 2.93% | 5.6% |
| 2 Years | 24.3% | 28.22% |
| 3 Years | 22.92% | 24.61% |
| 4 Years | 15.57% | 16.84% |
| 5 Years | 19.31% | 19.57% |
| 7 Years | 20.64% | 22.21% |
| 10 Years | 13.71% | 12.73% |
Asset allocationas on Sep 30, 2025
Large Cap 48.72%
Mid Cap 20.59%
Small Cap 30.13%
Other Cap 0%
Top holdings
Top sectors
Healthcare 99.44000000000001%
Credit quality
Bifurcation by Credit Quality is not available for this fund
Top Debt Holdings
Bifurcation by Holding is not available for this fund
Allocation by Instruments
Repo 0.46%
Net Current Assets 0.1%
Margin Money 0.00264371%
Other Holdings
Others 0.1%
Key risk & return ratios Compared to other funds in the category
About this fund
More funds from Nippon India Mutual Fund
Frequently asked questions
ET Money rank
App exclusive
#NA
- Return Outperformance: This fund has generated highest return amongst Sectoral-Pharma funds in the last 10 Years.
- Age: This is the 2nd oldest Sectoral-Pharma fund.
- Return Consistency: This fund ranks lower in terms of generating consistent return in it's category.
- Return/Risk: The fund is performing poorly than its category.
- Exit Load: Exit load of 1% if redeemed within 1 month.